-
Je něco špatně v tomto záznamu ?
Biochemistry of very-long-chain and long-chain ceramides in cystic fibrosis and other diseases: The importance of side chain
D. Garić, JB. De Sanctis, J. Shah, DC. Dumut, D. Radzioch,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
Grantová podpora
POP90155
CIHR - Canada
- MeSH
- bronchiální astma metabolismus MeSH
- ceramidy chemie metabolismus MeSH
- cystická fibróza metabolismus MeSH
- lidé MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Ceramides, the principal building blocks of all sphingolipids, have attracted the attention of many scientists around the world interested in developing treatments for cystic fibrosis, the most common genetic disease of Caucasians. Many years of fruitful research in this field have produced some fundamentally important, yet controversial results. Here, we aimed to summarize the current knowledge on the role of long- and very-long- chain ceramides, the most abundant species of ceramides in animal cells, in cystic fibrosis and other diseases. We also aim to explain the importance of the length of their side chain in the context of stability of transmembrane proteins through a concise synthesis of their biophysical chemistry, cell biology, and physiology. This review also addresses several remaining riddles in this field. Finally, we discuss the technical challenges associated with the analysis and quantification of ceramides. We provide the evaluation of the antibodies used for ceramide quantification and we demonstrate their lack of specificity. Results and discussion presented here will be of interest to anyone studying these enigmatic lipids.
Department of Human Genetics McGill University Montreal QC Canada
Department of Medicine Division of Experimental Medicine McGill University Montreal QC Canada
Department of Pharmacology and Experimental Therapeutics McGill University Montreal QC Canada
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034711
- 003
- CZ-PrNML
- 005
- 20191017090733.0
- 007
- ta
- 008
- 191007s2019 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.plipres.2019.03.001 $2 doi
- 035 __
- $a (PubMed)30876862
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Garić, Dušan $u Department of Human Genetics, McGill University, Montreal, QC, Canada.
- 245 10
- $a Biochemistry of very-long-chain and long-chain ceramides in cystic fibrosis and other diseases: The importance of side chain / $c D. Garić, JB. De Sanctis, J. Shah, DC. Dumut, D. Radzioch,
- 520 9_
- $a Ceramides, the principal building blocks of all sphingolipids, have attracted the attention of many scientists around the world interested in developing treatments for cystic fibrosis, the most common genetic disease of Caucasians. Many years of fruitful research in this field have produced some fundamentally important, yet controversial results. Here, we aimed to summarize the current knowledge on the role of long- and very-long- chain ceramides, the most abundant species of ceramides in animal cells, in cystic fibrosis and other diseases. We also aim to explain the importance of the length of their side chain in the context of stability of transmembrane proteins through a concise synthesis of their biophysical chemistry, cell biology, and physiology. This review also addresses several remaining riddles in this field. Finally, we discuss the technical challenges associated with the analysis and quantification of ceramides. We provide the evaluation of the antibodies used for ceramide quantification and we demonstrate their lack of specificity. Results and discussion presented here will be of interest to anyone studying these enigmatic lipids.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a bronchiální astma $x metabolismus $7 D001249
- 650 _2
- $a ceramidy $x chemie $x metabolismus $7 D002518
- 650 _2
- $a cystická fibróza $x metabolismus $7 D003550
- 650 _2
- $a lidé $7 D006801
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a De Sanctis, Juan B $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
- 700 1_
- $a Shah, Juhi $u Department of Pharmacology and Experimental Therapeutics, McGill University, Montreal, QC, Canada.
- 700 1_
- $a Dumut, Daciana Catalina $u Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, QC, Canada.
- 700 1_
- $a Radzioch, Danuta $u Department of Human Genetics, McGill University, Montreal, QC, Canada; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic; Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, QC, Canada. Electronic address: danuta.radzioch@mcgill.ca.
- 773 0_
- $w MED00003927 $t Progress in lipid research $x 1873-2194 $g Roč. 74, č. - (2019), s. 130-144
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30876862 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191017091201 $b ABA008
- 999 __
- $a ok $b bmc $g 1451371 $s 1073261
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 74 $c - $d 130-144 $e 20190312 $i 1873-2194 $m Progress in lipid research $n Prog Lipid Res $x MED00003927
- GRA __
- $a POP90155 $p CIHR $2 Canada
- LZP __
- $a Pubmed-20191007
